Document:

<PAGE>   1

                                                                    EXHIBIT 10.8

                               TECHNOLOGY LICENSE
                                      AND
                             DISTRIBUTION AGREEMENT

      This Technology License and Distribution Agreement (the "Agreement") is
entered into this ___ day of December, 1995 (the "Effective Date") between Sun
Microsystems, Inc., acting by and through its Java Products Group ("SUN") with
its principal place of business at 2550 Garcia Avenue, Mountain View,
California 94043 and Symantec Corporation, a Delaware corporation with its
principal place of business at 10201 Torre Avenue, Cupertino, California
95014-2132 ("Licensee").

                                    RECITALS

      WHEREAS SUN wishes to license its JAVA(TM) programming language and
related technology, while maintaining compatibility among JAVA language based
products; and

WHEREAS SUN wishes to protect and promote certain trademarks used in connection
with JAVA technology; and

WHEREAS Licensee wishes to develop and distribute products based upon SUN's
JAVA technology;

NOW THEREFORE, SUN and Licensee enter into this Technology Licensing and
Distribution Agreement on the following terms.

1.0   DEFINITIONS

      1.1 "Applet Application Programming Interface or AAPI" means the public
application programming interface to the Technology, including all public class
libraries and interfaces.

      1.2 "Applet" means a Java application which (i) runs on the AAPI and (ii)
consists of Java byte codes executable by the Java Runtime interpreter (but
does not include or incorporate the Java Runtime interpreter or Applet Classes).

      1.3 "Applet Classes" means the Java classes listed in Exhibit A.

      1.4 "Documentation" means users' manuals and programmers' and system
guides which SUN provides for use with the Technology and which are more
particularly identified in Exhibit A.

      1.5 "Derivative Work(s)" means: (i) for material subject to copyright or
mask work right protection, any work which is based upon one or more
pre-existing works of the Technology, such as a revision, modification,
translation, abridgement, condensation, expansion, collection, compilation or
any other form in which such pre-existing works may be recast, transformed or
adapted, (ii) for patentable or patented materials, any adaptation, subset,
addition, improvement or combination of the Technology, and (iii) for material
subject to trade secret protection, any new material, information or data
relating to and derived from the Technology, including new material which may
be protectable by copyright, patent or other proprietary rights, and, with
respect to each of the above, the preparation, use and/or distribution of
which, in the absence of this Agreement or other authorization from the owner,
would constitute infringement under applicable law. Derivative Works
specifically excludes Product(s), Value Added Open Packages, and
Licensee-implemented modifications to the Platform-Dependent Part of the Java
Runtime Interpreter.

      1.6 "Intellectual Property Rights" means all intellectual property rights
worldwide arising under statutory or common law, and whether or not perfected,
including, without limitation, all (i) patents, patent applications and patent
rights; (ii) rights associated with works of authorship including copyrights,
copyright applications, copyright registrations, mask work rights, mask work
applications, mask work registrations; (iii) rights relating to the protection
of trade secrets and confidential

<PAGE>   2
information; (iv) any right analogous to those set forth in this Section 1.6
and any other proprietary rights relating to intangible property (other than
trademark, trade dress, or service mark rights); and (v) divisions,
continuations, renewals, reissues and extensions of the foregoing (as and to
the extent applicable) now existing, hereafter filed, issued or acquired.

     1.7  "Java Compiler" means the Java programs more particularly identified
as "Technology: Compiler" in Exhibit A.

     1.8  "Java Runtime Interpreter" means the program which implements the
Java Virtual Machine, as specified in the Java Virtual Machine Specification.
The Java Runtime Interpreter consists of the Shared Part and the
Platform-Dependent Part.

     1.9  "Platform Dependent Part" means those source code files of the
Technology which are not in a "share" directory or subdirectory thereof as
provided by SUN and which must be compiled with the Shared Part to produce the
Java Runtime Interpreter.

     1.10 "Product(s)" means Licensee's current and future services and/or
product(s) which implement, integrate and/or embody in whole or in part, the
Technology and/or Licensee-developed Derivative Works thereof, for the
platforms specified in Exhibit C or any additional platforms developed by
Licensee or supplied by third parties. A current list of Product(s) is
specified in Exhibit B which may be amended by Licensee to add Product(s) from
time to time. "Product" must represent a significant functional and value
enhancement to the Technology such that the primary reason for a customer to
license such Product is other than the right to receive a license to the
Technology. "Product" must operate in conjunction with the Technology and shall
not include or be marketed as a technology which replaces or substitutes for
the Technology.

     1.11 "Shared Part" means those source code files of the Technology which
are in any "share" directory or subdirectory thereof as provided by SUN which
must be compiled with the Platform Dependent Part to produce the Java Runtime
Interpreter.

     1.12 "Source Code" means the human readable version, in whole or in part,
of the Technology supplied to Licensee and any corresponding comments and
annotations.

     1.13 "Technology" means the Java Runtime Interpreter, the Java Compiler
and the Applet Classes developed by SUN, as more particularly identified in
Exhibit A, and Upgrades thereto.

     1.14 "Trademarks" means ad names, logos, designs, characters, and other
designations or brands used by SUN in connection with the Technology.

     1.15 "Upgrades" means any bug fixes, modifications, variations,
enhancements, or dot releases of the Technology for the platform(s) specified
in Exhibit C, which SUN generally licenses as part of the Technology. The term
"Upgrades" does not include parts of the Technology to additional platform(s).

     1.16 "Value Added Open Packages" means additional Java classes developed
by Licensee which represent extensions to the AAPI, and which are made
available to third parties in either source or binary form to use in the
development of additional software which outputs Java bytecodes and/or runs in
the context of a Java compatible Runtime Interpreter environment.

2.0  LICENSE GRANTS

     2.1  Source Code License

          a.   Subject to the terms and conditions contained in this Agreement,
     SUN hereby grants to Licensee, and Licensee hereby accepts, under the
     Intellectual Property Rights of SUN, a perpetual, worldwide, non-exclusive,
     non-transferable license, without the right to sublicense (except as
     specified in Section 2.1b(iii), to access, use, modify, reproduce and view
     the Technology in Source Code form, solely for the purpose(s) of porting,
     developing, compiling to binary form and supporting Product(s), Value Added
     Open Packages, and Licensee-implemented modifications to the Platform
     Dependent Part. Licensee shall have no right to modify the interface or the
     functional behavior of the Java Runtime Interpreter or the Applet Classes
     and explicitly shall not have the right to modify or create a subset of the
     AAPI.

                                       2

<PAGE>   3
     Licensee may use the Source Code of the Shared Part of the Java Runtime
     Interpreter to develop Product(s), Value Added Open Packages, and
     Licensee-implemented modifications to the Platform Dependent Part, but if
     it uses such Source Code, it must use all of it without modification.

     Except as specified in Section 2.1b(iii) and 2.1(d), Licensee shall have
     no right to distribute the Source Code of the Technology or of Derivative
     Works, whether alone or as incorporated with Product(s), Value Added Open
     Packages, Licensee-implemented modifications to the Platform Dependent
     Part or Upgrades.

     b.   Porting.

          (i) Licensee may port the Platform Dependent Part to platforms other
     than those specified in Exhibit C.

          (ii) SUN will work with Licensee to identify any changes which are
     necessary to the Shared Part of the Java Runtime Interpreter to allow
     porting it to other platforms, and SUN will use reasonable efforts to make
     changes necessary to the code for the Shared Part.

          (iii) Licensee may sublicense and deliver a copy of the Source Code
     of the Technology to third parties only in association with the delivery
     and sublicensing of Licensee Products, and solely for the purposes of
     enabling such third party to port or localize Products for Licensee. Any
     such sublicense shall be made subject to terms and conditions relating to
     ownership, use, compatibility, and confidentiality of the Technology
     substantially similar to those contained herein.

     c.   Bug Fixes. Licensee will inform Sun promptly, and no later than it
     informs any third party, of any bugs identified in the Technology, and to
     the extent that Licensee elects to correct such bugs, Licensee will make
     such bug fixes promptly available to Sun free of all restrictions as they
     are implemented.

     d.   In the event that SUN distributes a development environment for
     commercial use, certain libraries of which are made available in Source
     Code form, free of charge to licensees by way of an electronically
     executable license via the Internet, Licensee may distribute such
     unmodified Source Code integrated into commercial quality Product(s), but
     only in a manner consistent with SUN's then-current business practices and
     subject to SUN's then-current licensing terms.

2.2  Binary Code License

     a.   SUN hereby grants and Licensee hereby accepts a non-exclusive,
     worldwide, fully paid up license to use an unlimited number of copies of
     the Technology in binary form, for Licensee's internal use during the term
     of this Agreement.

     b.   Worldwide Distribution. Licensee may distribute the Product(s), Value
     Added Open Packages, Licensee-implemented modifications to the Platform
     Dependent Part, Upgrades and associated Documentation provided to Licensee
     by SUN in binary form worldwide and may use such distribution channels as
     Licensee deems appropriate, including distributions, resellers, dealers
     and sales representatives (collectively, "Distributors"), provided,
     however, that such Distributors shall not modify the Technology or any
     portions thereof, and shall be obligated to abide by the relevant terms in
     this Agreement governing use, distribution, compatibility, and
     confidentiality.

2.3  Documentation

     a.   SUN hereby grants to Licensee, and Licensee hereby accepts, under
     SUN's Intellectual Property Rights, a non-exclusive, non-transferable
     license (i) to use and distribute the unmodified Documentation, (ii) to use
     and modify the Documentation to create technically accurate unaltered
     subsets of the documentation which shall include all the relevant SUN

                                       3

<PAGE>   4
     copyrights, notices and marks, (iii) to translate the Documentation into
     other languages, and (iv) to distribute such translated or modified
     Documentation in connection with distribution of the Product(s). Licensee
     may also use a pointer to the SUN Documentation on the Internet in
     connection with distribution of the Product(s).

2.4 Compatibility

     a.   Java Compatibility

     (i) Initially, the AAPI shall be that which is reflected in the Technology
     as identified in Exhibit A, by the bytecode specification in the
     Documentation entitled "Java Virtual Machine Specification" and by the
     Java language specification in the Documentation entitled "Java Language
     Specification." Subsequently, the AAPI may be modified by SUN and SUN will
     give Licensee written notice thereof.

     (ii) From time to time, SUN will make publicly available test suites at no
     cost for validating that the portion of Licensee's Product which interprets
     Java bytecodes complies with the then-current Specification of the AAPI as
     defined by SUN as of the date of that test suite ("Java Test Suite"). SUN
     shall not publish more than four (4) versions of such Java Test Suites in
     any one (1) calendar year, without the consent of Licensee, which consent
     shall not be unreasonably delayed or denied. SUN shall use reasonable
     efforts to review any changes to such Java Test Suites as much in advance
     as possible with Licensee, but failure of SUN to do so shall not constitute
     a breach of this Agreement and shall not invalidate any such Java Test
     Suite published by SUN. Changes to Java Test Suites to correct errors shall
     not be counted against the limitation to four (4).

     (iii) Each revision of a Product released by Licensee must pass the Java
     Test Suite that was current one hundred twenty (120) days before First
     Customer Shipment of such Product. Licensee shall not release or
     distribute to any third party the portion of Licensee's Product that
     interprets Java bytecodes, which does not successfully pass such Java Test
     Suite.

     (iv) If Licensee provides SUN with written notice of the existence of a
     bug in a current Java Test Suite, then Licensee shall be released from
     compatibility with the minimum portion of such Java Test Suite necessary
     to avoid the impact of such bug, until such time as Sun provides to
     Licensee a corrected or new Java Test Suite.

     (v) Branding and Trademarks. Licensee shall use a logo specified by SUN
     that indicates compatibility with the Java Test Suites (the "Java
     Compatibility Logo") in a trademark manner on all Licensee Product(s)
     distributed hereunder. The terms and conditions governing the parties'
     agreement as to trademarks, logos, and branding shall be governed by the
     Trademark License entered into herewith, attached as Exhibit F hereto, and
     incorporated by reference herein.

     b.   Compiler Compatibility

     (i) Any Product(s) that performs a compiling function must continue to
     compile the complete Java Language as described in the Java Language
     Specification, and be able to generate fully-interpretable
     machine-independent bytecodes for the Java Virtual Machine.

     (ii) From time to time, SUN will make publicly available test suites at no
     cost for validating that the portion of Licensee's Product which compiles
     the Java Language complies with the then-current Java Language
     specification and bytecode specification as defined by SUN as of the date
     of that test suite ("Java Language Test Suite"). Without the consent of
     Licensee, which consent shall not be unreasonably delayed or denied, SUN
     shall not supply more than four (4) versions of such Java Language Test
     Suites in any one (1) calendar year. SUN shall use reasonable efforts to
     review any changes to such Java Language Test Suites as much in advance as
     possible with Licensee, but failure of SUN to do so shall not constitute a
     breach of

                                       4
<PAGE>   5
      this Agreement and shall not invalidate any such Java Language Test Suite
      supplied by SUN. Changes to Java Language Test Suites to correct errors
      shall not be counted against the limitation to four (4).

      c.    Upgrades. Licensee shall promptly announce and ship Product(s) based
      on Upgrades to the Technology as delivered by SUN during the term of this
      Agreement. Licensee shall correct any incompatibility with the AAPI, as
      determined by the applicable Java or Java Language Test Suite, which
      arises from integrating such Upgrade, whether such incompatibility is
      detected before or after FCS of the affected Product(s). If Licensee
      discovers that a new Product or a new version of a Product is incompatible
      before the Product enters beta stage, Licensee shall not ship such
      incompatible Product(s) without first correcting the incompatibility.

      2.5.  Value Added Open Packages

      (i)   Licensee shall deliver to SUN free of all restrictions the
      specification for the application programming interface for Value Added
      Open Package as early as is reasonably possible but in no event later than
      the date on which it first provides such specification or an
      implementation thereof to any third party. Included in such specification
      shall be an appropriate test suite sufficiently detailed to allow SUN and
      third parties to produce implementations compatible with the
      specification. Licensee shall use its reasonable commercial efforts to
      clarify and correct the specification or the test suite upon written
      request by SUN and failure to do so within sixty (60) days after such
      request shall constitute breach of this Agreement.

      (ii)  Licensee shall notify SUN as soon as it has made any general
      disclosure (i.e., not subject to confidentiality obligations) of such
      specification, or first releases a Product implementing such
      specification, after which SUN shall have no obligation of confidentiality
      whatsoever with respect to such specification. Licensee agrees that it
      will take no steps whatsoever to prevent SUN or any third party from
      creating implementations based on such specification, provided that such
      implementations do not violate Licensee's patents, copyrights (except that
      Licensee agrees that it will not enforce copyright or patent claims that
      relate to interface or compatibility) or trade secrets in the
      implementation of the Value Added Open Packages.

      (iii) Licensee shall confine the names of all Value Added Open Packages to
      names beginning with "COM.Licensee" or such other convention as SUN may
      reasonably require and shall not modify or extend the public class or
      interface declarations whose names begin with "java", "COM.sun" or their
      equivalents in any subsequent naming convention. Licensee will make
      reasonable commercial efforts to ensure that other commercial software
      packages which it redistributes conform to this convention.

      (iv)  Licensee hereby grants and SUN hereby accepts a non-exclusive,
      worldwide, fully-paid-up license to use an unlimited number of copies of
      the Value Added Open Packages, in binary form, for SUN's internal use,
      such use including but not limited to demonstration rights. Licensee
      agrees to reasonably negotiate in good faith with SUN the terms of a
      commercial license for the source code of the Value Added Open Packages.
      The parties agree that the fees and other terms and conditions of this
      Agreement are a reasonable standard against which to judge such a license
      on a proportionate basis comparing the scope and complexity of the portion
      of the Value Added Open Package being licensed to the scope and complexity
      of the Technology.

2.6   Ownership

      a.    Ownership by SUN. SUN retains all right, title and interest in the
      Technology, including Derivative Works, Documentation, Upgrades, bug
      fixes, and Trademarks, and associated Intellectual Property Rights, but
      excluding Product(s), Value Added Open Packages and Licensee-implemented
      modifications to the Platform-Dependent Part of the Java Runtime
      Interpreter, subject to SUN's underlying rights in the Technology and
      associated Intellectual Property Rights. Licensee agrees to execute (in
      recordable form where appropriate) any instruments and/or documents as
      SUN may reasonably request to verify and maintain SUN's

                                       5
<PAGE>   6
     ownership rights, or to transfer any part of the same which may vest in
     Licensee for any reason. Licensee further agrees to promptly deliver to SUN
     any Derivative Works of the Technology created by Licensee pursuant to and
     during the term of this Agreement. SUN shall have no obligations of
     confidentiality to Licensee for such Derivative Works, nor shall SUN be
     obligated to incorporate any such Derivative Works into the Technology.

     b.   Ownership by Licensee. Licensee retains all right, title and interest
     in the Product(s), Value Added Open Packages, and Licensee-implemented
     modifications to the Platform-Dependent Part of the Java Runtime
     Interpreter, created by Licensee pursuant to and during the term of this
     Agreement, subject to SUN's underlying rights in the Technology and
     associated Intellectual Property Rights identified in Section 2.6a. In the
     event that the parties desire to undertake joint development activities,
     the parties agree to negotiate and enter into a separate joint development
     agreement for such activities.

     2.7  Protection of SUN's Rights. Licensee shall use, modify and practice
the Technology and manufacture, market, distribute and sell Product(s), Value
Added Open Packages, and Licensee-implemented modifications to the
Platform-Dependent Part of the Java Runtime Interpreter only in a manner
consistent with the terms of this Agreement, and only in a manner reasonably
designed not to jeopardize or prejudice SUN's Intellectual Property Rights,
including trademarks, trade dress and service marks, and other proprietary
rights.

     2.8  No Right To Sublicense or Transfer. Except as specifically provided
in Section 2.1b(iii) above, Licensee shall have no right to sublicense or
transfer any of the rights or licenses granted in this Agreement.

     2.9  No Other Grant. Each party agrees that this Agreement does not grant
any right or license, under any Intellectual Property Rights of the other
party, or otherwise, except as expressly provided in this Agreement, and no
other right or license is to be implied by or inferred from any provision of
this Agreement or by the conduct of the parties.

     2.10 Contractors. Licensee may retain third parties to furnish services to
it in connection with its development and manufacture of Product(s); provided,
however, that all such third parties who perform work in furtherance of such
activities shall execute appropriate documents: (i) acknowledging their
work-made-for-hire status, (ii) affecting assignments of all Intellectual
Property Rights with respect to such work to Licensee or SUN, as appropriate,
and (iii) undertaking obligations of confidentiality respecting such work. SUN
may, upon its request, review any such form documents and agreements proposed
for use by Licensee prior to any such use of contractors for development or
manufacture of the Product(s).

     2.11 Value Added Requirement. Licensee will distribute the Technology only
as part of a Product and not on a stand-alone basis.

     2.12 Pre-Release. Licensee may release Product(s) based on the pre-FCS
Technology licensed by SUN hereunder only for beta testing purposes, except
that Licensee is hereby authorized to release a beta version of the Technology
integrated into Licensee's C++ 7.2 for Windows 95/NT as a patch on the Internet
(the "Patch"), provided, that such Patch: (i) shall be beta quality software,
(ii) shall meet all the compatibility requirements specified in this Agreement
and (iii) will not require payment of a royalty to SUN until December 31, 1996.
Thereafter, any subsequent release(s) of Product(s) incorporating the Patch
will be deemed Product(s) hereunder and subject to payment of royalties as
specified in Exhibit B.

3.0  SUPPORT AND UPGRADES

     3.1  During the Support Period (as defined below), SUN shall provide to
Licensee under the terms and conditions of this Agreement, Upgrades for
the platforms specified in Exhibit C when and if any such Upgrades are made
available by SUN to any commercial licensee similarly situated.

     3.2  SUN shall assign the equivalent of one (1) half-time engineer to be
available via phone, electronic mail and/or scheduled appointment during
regular business hours to support Licensee,

                                       6
<PAGE>   7
from the Effective Date through the fifth (5th) anniversary of Licensee's
receipt of the "First Customer Shipment" version of any of the platforms
identified in Exhibit C (the "SUN FCS Date") (the "Support Period"). The
selection of the support engineer shall be at Sun's sole discretion. Licensee
may designate a maximum of three (3) contacts to interface with the SUN support
engineer.

     3.3  Upon the request of Licensee, SUN agrees to reasonably negotiate in
good faith for additional support through a separate support agreement.

4.0  PAYMENT

     4.1  Royalties. In consideration of the rights granted Licensee in this
Agreement, Licensee shall pay to SUN the royalties set forth in Exhibit C.
Payment of royalties shall be made quarterly, shall be due thirty (30) days
following the end of the calendar quarter to which they relate and shall be
submitted with a written statement certifying the number of Products sold and
showing the calculation of royalties due.

     4.2  Support and Upgrade Fees. During the Support Period, Support and
Upgrades shall be provided to Licensee at no charge.

     4.3  Taxes. All payments required by this Agreement shall be made in
United States dollars, are exclusive of taxes, and Licensee agrees to bear and
be responsible for the payment of all such taxes, including, but not limited
to, all sales, use, rental receipt, personal property or other taxes and their
equivalents which may be levied or assessed in connection with this Agreement
(excluding only taxes based on Sun's net income).

     4.4  Records. Licensee shall maintain account books and records consistent
with Generally Accepted Accounting Principles appropriate to Licensee's
domicile, as may be in effect from time to time, sufficient to allow the
correctness of the royalties required to be paid pursuant to this Agreement to
be determined.

     4.5  Audit Rights. SUN shall have the right to audit such accounts upon
reasonable prior notice. The right to audit may be exercised through an
independent auditor or SUN's choice (the "Auditor"). The Auditor shall be bound
to keep confidential the details of the business affairs of Licensee and to
limit disclosure of the results of any audit to only the sufficiency of the
accounts and the amount, if any, of any additional payment or other payment
adjustment that should be made. Such audits shall not occur more than once each
year (unless discrepancies are discovered in excess of the five percent (5%)
threshold set forth in Section 4.6, in which case two consecutive quarters per
year may be audited). Except as set forth in Section 4.6 below, SUN shall bear
all costs and expenses associated with the exercise of its rights to audit.

     4.6  Payment Errors. In the event that any errors in payments shall be
determined, such errors shall be corrected by appropriate adjustment in payment
for the quarterly period during which the error is discovered. In the event of
an underpayment of more than five percent (5%) of the proper amount owed, upon
such underpayment being properly determined by the Auditor, Licensee shall
reimburse SUN the amount of said underpayment and the reasonable charges of the
Auditor in performing the audit that identified said underpayment, and interest
on the overdue amount at the maximum allowable interest rate from the date of
accrual of such obligation.

5.0  ADDITIONAL AGREEMENT OF PARTIES

     5.1  Notice of Breach or Infringement. Each party shall notify the other
immediately in writing when it becomes aware of any breach or violation of the
terms of this Agreement, or when Licensee becomes aware of any potential or
actual infringement by a third party of the Technology or SUN's Intellectual
Property Rights therein.

     5.2  Notices. Licensee shall not remove any copyright notices, trademark
notices or other proprietary legends of SUN or its suppliers contained on or in
the Technology or Documentation. Each unit of Product(s) containing the
Technology distributed by Licensee shall include in Licensee's documentation,
or in other terms and conditions of sale, notices substantially similar to
these contained on and in the Technology. Licensee or its Distributors shall
require an end user license

                                       7
<PAGE>   8
agreement for each unit of Product(s) shipped and Licensee shall provide SUN
with a copy of such form agreement for review and approval. If Licensee or its
Distributors use a package design or label for the Product(s), such package
design or label shall include an acknowledgement of SUN as the source of the
Technology and such other notices as specified in Exhibit F. In addition,
Licensee shall comply with all reasonable requests by SUN to include SUN's
copyright and/or other proprietary rights notices on the Product(s),
documentation or related materials, including but not limited to the notices
and acknowledgements as specified in Exhibit F.

     5.3  Applet Tags. Any Product that reads or writes hypertext markup
language (HTML) or standard generalized markup language (SGML) shall use the
Document Type Definition ("DTD") as specified in Exhibit E when referencing the
Applet tag, unless another DTD is defined for the Applet tag by an industry
standard.

     5.4  End User Support. Licensee is not authorized to make any
representation or warranty on behalf of SUN to its end users or third parties.
Licensee shall provide technical and maintenance support service for its
distributors and end user customers in accordance with Licensee's standard
support practices. SUN shall not be responsible for providing any support to
Licensee's distributors or customers for the Technology or the Product(s).

     5.5  Marketing. Licensee will cooperate with SUN on mutually agreeable
marketing and promotional activities relating to the Technology. Licensee's
initial press announcement concerning execution of this Agreement must be
reviewed by SUN prior to its release.

     5.6  Use of Licensee's name. Licensee hereby authorizes SUN to use
Licensee's name in advertising, marketing, collateral, customer tests and
customer success stories prepared by or on behalf of SUN for the Technology,
provided that Licensee will have the right to approve the use of its name, such
approval not to be unreasonably withheld or delayed.

6.0  LIMITED WARRANTY AND DISCLAIMER

     6.1  Limited Warranty. SUN represents and warrants that the media on which
the Technology is recorded will be free from defects in materials and
workmanship for a period of ninety (90) days after delivery. SUN's sole
liability with respect to breach of this warranty is to replace the defective
media. Except as expressly provided in this Section 6.1, SUN licenses the
Technology and Documentation to licensee on an "AS IS" basis.

     6.2  General Disclaimer. EXCEPT AS SPECIFIED IN THIS AGREEMENT, ALL
EXPRESS OR IMPLIED REPRESENTATIONS AND WARRANTIES, INCLUDING ANY IMPLIED
WARRANTY OF MERCHANTABILITY, FITNESS FOR A PARTICULAR PURPOSE OR
NON-INFRINGEMENT, ARE HEREBY DISCLAIMED.

     6.3  Logo Disclaimer. SUN MAKES NO WARRANTIES OF ANY KIND RESPECTING THE
COMPATIBILITY LOGO(s), INCLUDING THE VALIDITY OF SUN'S RIGHTS IN THE
COMPATIBILITY LOGO(s) IN ANY COUNTRY, AND DISCLAIMS ANY AND ALL WARRANTIES THAT
MIGHT OTHERWISE BE IMPLIED BY APPLICABLE LAW, INCLUDING WARRANTIES AGAINST
INFRINGEMENT OF THIRD PARTY TRADEMARKS.

     6.4  Limitation. The warranties set forth in this Article 6.0 are
expressly subject to Section 9.0 (Limitation of Liability).

7.0  CONFIDENTIAL INFORMATION

     7.1  Confidential Information. For the purposes of this Agreement,
"Confidential Information" means the Technology and that information which
relates to (i) SUN hardware or software, (ii) Licensee hardware or software,
(iii) the customer lists, business plans and related information of either
party, and (iv) any other technical or business information of the parties,
including the terms and conditions of this Agreement. In all cases, information
which a party wishes to be treated as "Confidential Information" shall be
marked as "confidential" or "proprietary" (or with words of similar import) in
writing by the disclosing party on any tangible manifestation of the
information transmitted in connection with the disclosure, or, if disclosed
orally, designated as "confidential" or "proprietary"

                                       8
<PAGE>   9

(or with words of similar import) at the time of disclosure. SUN has no
obligation of confidentiality to Licensee with respect to Derivative Works and
the specifications of the Value Added Open Packages.

     7.2  Preservation of Confidentiality. The parties agree that all
disclosures of Confidential Information (as defined under Section 7.1 above)
shall be governed by and treated in accordance with the terms of the
Confidential Disclosure Agreement (the "CDA") attached hereto as Exhibit D and
incorporated herein by reference, modified as follows:

          (a)  the definition of "Confidential Information" shall be as set
               forth in section 7.1 above notwithstanding any definition set
               forth in the CDA;

          (b)  the use of Confidential Information shall be limited to the
               scope of the licenses provided in this Agreement; and

          (c)  the obligations of confidentiality expressed in the CDA shall
               extend three (3) years beyond termination of this Agreement,
               except with respect to Sun Source Code which shall be held
               confidential in perpetuity.

8.0  LIMITED INDEMNITY

     8.1  The parties acknowledge that the Technology is in pre-release form and
that SUN shall not be liable for any defects or deficiencies in the Technology
or in any Product, process or design created by, with or in connection with the
Technology whether or not such defects and/or deficiencies are caused, in whole
or in part, by defects or deficiencies in the design or implementation of the
Technology. Upon FCS of the Technology by SUN, Sun will provide to Licensee a
limited indemnity as described in Sections 8.2-8.5 below.

     8.2  SUN will defend, at its expense, any legal proceeding brought against
Licensee, to the extent it is based on a claim that use of the FCS or
subsequent version(s) of the Technology, (excluding pre-release versions) ("FCS
Technology") is a direct infringement of a Berne Convention copyright, and will
pay all damages awarded by a court of competent jurisdiction attributable to
such claim, provided that Licensee: (i) provides notice of the claim promptly
to SUN; (ii) gives SUN sole control of the defense and settlement of the claim;
(iii) provides to SUN, at SUN's expense, all available information, assistance
and authority to defend; and (iv) has not compromised or settled such
proceeding without SUN's prior written consent.

     8.3  Should any FCS Technology or any portion thereof become, or in SUN's
opinion be likely to become, the subject of a claim of infringement for which
indemnity is provided under Section 8.2, SUN shall, as Licensee's sole and
exclusive remedy, elect to: (i) obtain for Licensee the right to use such FCS
Technology; (ii) replace or modify the FCS Technology so that it becomes
non-infringing; or (iii) accept the return of the Technology and grant Licensee
a refund of the License Fee and royalties, as depreciated on a five year
straight-line basis.

     8.4  SUN shall have no liability for any infringement or claim which
results from: (i) use of other than a current unaltered version of the FCS
Technology, if such version was made available to Licensee; (ii) use of the FCS
Technology in combination with any non-Sun-provided equipment, software or
data; or (iii) SUN's compliance with designs or specifications of Licensee.

     8.5  THIS ARTICLE STATES THE ENTIRE LIABILITY OF SUN WITH RESPECT TO
INFRINGEMENT OF ANY INTELLECTUAL PROPERTY RIGHTS BY THE TECHNOLOGY. SUN SHALL
HAVE NO LIABILITY WITH RESPECT TO INFRINGEMENT OF INTELLECTUAL PROPERTY RIGHTS
OF LICENSEE OR ANY THIRD PARTY AS A RESULT OF USE, LICENSE, OR SALE OF
TECHNOLOGY.

     8.6  Indemnity by Licensee. Licensee shall defend and indemnify SUN from
any and all claims brought against SUN by third parties, and shall hold SUN
harmless from all corresponding damages, liabilities, costs and expenses,
(including reasonable attorneys' fees) incurred by SUN arising out of or in
connection with Licensee's use, reproduction or distribution of the Technology
or Product(s).

9.0  LIMITATION OF LIABILITY

                                       9

<PAGE>   10
     9.1 Limitation of Liability. Except for express undertakings to indemnify
under this Agreement and/or breach of Sections 2.4, 2.5, 7.0 or 9.2:

a. Each party's liability to the other for claims relating to this Agreement,
whether for breach or in tort, shall be limited to one million dollars
($1,000,000).

b. IN NO EVENT WILL EITHER PARTY BE LIABLE FOR ANY INDIRECT, INCIDENTAL,
SPECIAL, CONSEQUENTIAL OR PUNITIVE DAMAGES IN CONNECTION WITH OR ARISING OUT
OF THIS AGREEMENT (INCLUDING LOSS OF PROFITS, USE, DATA, OR OTHER ECONOMIC
ADVANTAGE), NO MATTER WHAT THEORY OF LIABILITY, EVEN IF THE EXCLUSIVE REMEDIES
PROVIDED FOR IN THIS AGREEMENT FAIL OF THEIR ESSENTIAL PURPOSE AND EVEN IF
EITHER PARTY HAS BEEN ADVISED OF THE POSSIBILITY OR PROBABILITY OF SUCH
DAMAGES. FURTHER, LIABILITY FOR SUCH DAMAGE SHALL BE EXCLUDED, EVEN IF THE
EXCLUSIVE REMEDIES PROVIDED FOR IN THIS AGREEMENT FAIL OF THEIR ESSENTIAL
PURPOSE. The provisions of this Section 9.0 allocate the risks under this
Agreement between Sun and Licensee and the parties have relied upon the
limitations set forth herein in determining whether to enter into this
Agreement.

     9.2 High Risk Activities. The Technology is not fault-tolerant and is not
designed, manufactured or intended for use or resale as on-line control
equipment in hazardous environments requiring fail-safe performance, such as in
the operation of nuclear facilities, aircraft navigation or communication
systems, air traffic control, direct life support machines, or weapons systems,
in which the failure of the Technology or Product(s) could lead directly to
death, personal injury, or severe physical or environmental damage ("High Risk
Activities"). SUN specifically disclaims any express or implied warranty of
fitness for High Risk Activities. Licensee will not knowingly use, distribute
or resell the Technology or Products for High Risk Activities and will ensure
that its customers and end-users of its Products are provided with a copy of
the notice specified in the first sentence of this Section 9.2.

10.0 TERM AND TERMINATION

     10.1 Term. The term of this Agreement shall begin on the Effective Date
and shall continue for a period of five (5) years, or until terminated as
provided below. Each year for five (5) consecutive years following expiration
of the initial five (5) year term, at Licensee's sole option, Licensee may
extend the term of this Agreement for one (1) additional year. Licensee shall
indicate its intent to extend the Agreement by written notice to SUN within
thirty (30) days prior to the expiration of the preceding term. Termination is
permitted either for breach of this Agreement, upon thirty (30) days written
notice to the other party and an opportunity to cure within such thirty (30)
day period, or upon any action for infringement of Intellectual Property Rights
relating to the Technology by Licensee against SUN or any of SUN's licensees of
the Technology.

     10.2 Effect of Expiration. Upon expiration of this Agreement, SUN shall
retain use, under the terms of this Agreement, of the Intellectual Property
Rights received hereunder, and Licensee shall be authorized to: (i) distribute
Product(s) containing the version of the Technology incorporated therein at the
time of expiration, subject to Licensee's continued compliance with the Test
Suites current at the time of expiration, and payment of royalties, and (ii)
retain one (1) copy of the Technology in Source Code form to support customers
having copies of Product(s) distributed by Licensee prior to the expiration
hereof. All other rights of Licensee shall terminate upon such expiration.

     10.3 Effect of Termination. In the event of termination of this Agreement
by SUN in accordance with Section 10.1 above, Licensee shall promptly: (i)
return to SUN all copies of the Technology and Derivative Works thereof in
tangible or electronic form, Documentation, and Confidential Information
(collectively "SUN Property") (excluding Value Added Open Packages and
Licensee-implemented modifications to the Platform Dependent Part) in
Licensee's possession or control; or (ii) permanently destroy or disable all
copies of the SUN Property in Licensee's possession or control, except as
specifically permitted in writing by SUN; and (iii) provide SUN with a written
statement certifying that

                                       10

<PAGE>   11
Licensee has complied with the foregoing obligations. All rights and licenses
granted to Licensee shall terminate upon such termination.

     10.4  No Liability for Expiration or Lawful Termination. Neither party
shall have the right to recover damages or to indemnification of any nature,
whether by way of lost profits, expenditures for promotion, payment for
goodwill or otherwise made in connection with the business contemplated by this
Agreement, due to the expiration or permitted or lawful termination of this
Agreement. EACH PARTY WAIVES AND RELEASES THE OTHER FROM ANY CLAIM TO
COMPENSATION OR INDEMNITY FOR TERMINATION OF THE BUSINESS RELATIONSHIP UNLESS
TERMINATION IS IN MATERIAL BREACH OF THIS AGREEMENT.

     10.5  No Waiver. The failure of either party to enforce any provision of
this Agreement shall not be deemed a waiver of that provision. The rights of
SUN under this Section 10.0 are in addition to any other rights and remedies
permitted by law or under this Agreement.

     10.6  Survival. The parties' rights and obligations under Sections 2.0,
4.0, 5.2, 5.3, 6.0, 7.0, 8.0, 9.0, 10.0, and 11.0 shall survive expiration or
termination of this Agreement, excluding in the event of breach by Licensee,
Licensee's rights under Section 2.0, which shall terminate.

     10.7  Irreparable Harm. The parties acknowledged that breach of Sections
2.0, 5.2, 5.3, 7.0, 9.2, or 11.6 may cause irreparable harm, the extent of which
would be difficult to ascertain. Accordingly, they agree that, in addition to
any other legal remedies to which a non-breaching party might be entitled, such
party may seek immediate injunctive relief in the event of a breach of the
provisions of such Articles.

11.0  MISCELLANEOUS

      11.1  Notices. All notices must be in writing and delivered either in
person or by certified mail or registered mail, postage prepaid, return receipt
requested, to the person(s) and address specified below. Such notice will be
effective upon receipt.

<TABLE>
<CAPTION>
            SUN                                   Licensee
            <S>                                   <C>
            Sun Microsystems, Inc.                Symantec Corporation
            100 Hamilton Avenue                   10201 Torre Avenue
            Palo Alto, California 94301           Cupertino, California 95014
            Attn: Associate General Counsel       Attn: General Counsel
            Java Products Business
</TABLE>

      11.2  Partial Invalidity. If any term or provision of this Agreement is
found to be invalid under any applicable statute or rule of law then, that
provision notwithstanding, this Agreement shall remain in full force and effect
and such provision shall be deleted unless such a deletion would frustrate the
intent of the parties with respect to any material aspect of the relationship
established hereby, in which case, this Agreement and the licenses and rights
granted hereunder shall terminate.

      11.3  Complete Understanding. This Agreement and the Exhibits hereto
constitute and express the final, complete and exclusive agreement and
understanding between the parties with respect to its subject matter and
supersede all previous communications, representations or agreements, whether
written or oral, with respect to the subject matter hereof. No terms of any
purchase order or similar document issued by Licensee shall be deemed to add
to, delete or modify the terms and conditions of this Agreement. This Agreement
may not be modified, amended, rescinded, canceled or waived, in whole or part,
except by a written instrument signed by the parties.

      11.4  Language. This Agreement is in the English language only, which
language shall be controlling in all respects, and all versions of this
Agreement in any other language shall be for accommodation only and shall not
be binding on the parties to this Agreement. All communications and notices
made or given pursuant to this Agreement, and all documentation and support to
be provided, unless otherwise noted, shall be in the English language.

                                       11

<PAGE>   12
     11.5  Governing Law. This Agreement is made under and shall be governed by
and construed under the laws of the State of California, regardless of its
choice of laws provisions.

     11.6  Compliance with Laws. The Technology, including technical data, is
subject to U.S. export control laws, including the U.S. Export Administration
Act and its associated regulations, and may be subject to export or import
regulations in other countries. Licensee agrees to comply strictly with all such
regulations and acknowledges that it has the responsibility to obtain such
licenses to export, re-export or import the Technology or Product(s) as may be
required after delivery to Licensee.

     Licensee shall make reasonable efforts to notify and inform its employees
having access to the Technology of Licensee's obligation to comply with the
requirements stated in this Article.

     11.7  Disclaimer of Agency.  The relationship created hereby is that of
licensor and licensee and the parties hereby acknowledge and agree that nothing
herein shall be deemed to constitute Licensee as a franchisee of SUN. Licensee
hereby waives the benefit of any state or federal statutes dealing with the
establishment and regulation of franchises.

     11.8  Delivery. As soon as practicable after the Effective Date, SUN shall
deliver to Licensee one (1) copy of each of the deliverables set forth in
Exhibit A. Licensee acknowledges that certain of the deliverables are in various
stages of completion and agrees to accept the deliverables as and to the extent
completed as of the date of delivery and "AS IS." In the event any deliverable
is already in the possession or custody of Licensee, such item(s) shall, to the
extent used in connection with the rights granted in Section 2.0 above, be
subject to the terms of this Agreement, notwithstanding any pre-existing
agreement or understanding between Licensee and SUN with respect to such items.

     11.9  Assignment and Change in Control. This Agreement may not be assigned
by either party without the prior written consent of the other party, which
consent shall not be unreasonably withheld or delayed, except that SUN may
assign this Agreement to a majority-owned subsidiary.

     11.10  Construction.  This Agreement has been negotiated by SUN and
Licensee and by their respective counsel. This Agreement will be fairly
interpreted in accordance with its terms and without any strict construction in
favor of or against either party.

     11.11  Force Majeure.  Except for the obligation to pay money, neither
party shall be liable to the other party for non-performance of this Agreement,
if the non-performance is caused by events or conditions beyond that party's
control and the party gives prompt notice under Section 11.1 and makes all
reasonable efforts to perform.

     11.12

     The following are included herein by reference as integral parts of this
Agreement:

o   Exhibit A - Description of Technology and Documentation
o   Exhibit B - Identification of Licensee Product(s)
o   Exhibit C - Schedule of Royalties
o   Exhibit D - Confidential Disclosure Agreement
o   Exhibit E - Document Type Definition
o   Exhibit F - Trademark License

     11.13  Section References.  Any reference contained herein to an article of
this agreement shall be meant to refer to all subsections of the article.

                                       12
<PAGE>   13
     11.14  No Competitive Restrictions. The Parties agree that nothing in this
Agreement is intended to prohibit Licensee from independently developing or
acquiring technology that is the same as or similar to the Technology, provided
that Licensee does not do so in breach of Exhibit D to this Agreement.

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by
their duly authorized representatives.

SUN:                                     Licensee:

Sun Microsystems, Inc.

By:   /s/ ERIC SCHMIDT                   By:    /s/ DEREK WITTE
   ---------------------------               --------------------------

Name:     Eric Schmidt                   Name:      Derek Witte
      ------------------------                 ------------------------
         (Print or Type)                          (Print or Type)

Title:       CFO/VP                      Title:        VP
       -----------------------                  -----------------------

Date:       12/11/95                     Date:      12/11/95
       -----------------------                  -----------------------

                                       13
<PAGE>   14
                                   EXHIBIT A

                  DESCRIPTION OF TECHNOLOGY AND DOCUMENTATION

To the extent that SUN has not already delivered any of the following listed
items to Licensee as of the Effective Date of the Agreement to which this
Exhibit A is attached, SUN shall deliver each of the following items to
Licensee under the terms of the Agreement.

I. TECHNOLOGY: JAVA APPLET ENVIRONMENT

The Java Applet Environment consists of the following source code:

A. All the java files from the following Java Applet Packages:

            java.lang               Language Classes
            java.io                 Stream I/O
            java.net                Networking Classes
            java.util               General utilities
            java.applet             Applet Classes
            java.awt                Abstract Window Toolkit
            java.awt.image          Image Handling Classes
            java.awt.peer           Implementation Classes for awt

B. The source code for the Java Runtime Interpreter, which implements the Java
Virtual Machine, consisting of the Shared Part, identified as those files which
are in any "share" directory or subdirectory thereof, and the
Platform-Dependent Part, identified as other files which are compiled with the
"share" files to produce the Runtime Interpreter program.

II. TECHNOLOGY: COMPILER

The compiler consists of the development tools necessary for the creation,
modification, debugging, and analysis of Java Applets and Java classes. This
includes the debugger, profiler, native method stub generator, Applet viewer
and other software that is generally made available free of charge in binary
form as part of the compiler technology. This includes but is not limited
to the following source code:

            java.tools.asm          Assembler
            java.tools.debug        Debugging Classes
            java.tools.java         Parser helper Classes
            java.tools.javac        Compiler
            java.tools.javadoc      Documentation Generator
            java.tools.tree         Parse Tree Classes
            java.tools.tty          TTY Access to the Debugger

II. DOCUMENTATION:

Java Language Specification
Java API Documentation
Java Virtual Machine Specification
Java Programmer's Guide

                                       14
<PAGE>   15
                                   EXHIBIT B

                     IDENTIFICATION OF LICENSEE PRODUCT(S)

1. Language Products

            Symantec C++ environment for Windows and Macintosh with Java support
            Version of the SCALE database access software for the Java language

2. Vector Products

            Visual Rapid Application development tool for Windows and Macintosh
            for the Java language (Vector), and any subsequent or follow-on
            products or versions thereof regardless of the name of such product
            or version given by Licensee.

3. Browser Product

            CyberJack (Internet browser)

4. General and Other Product(s)

            Comsuite (suite of communications products)

                                       15
<PAGE>   16

                                   EXHIBIT C

                             SCHEDULE OF ROYALTIES

1) Royalties: Licensee shall pay to SUN the following royalties for the
following categories of Product(s):

          until December 31, 1996, [*] for Language Products described in
          Exhibit B; after December 31, 1996, [*] of the Language Product(s)
          distributed by or for Licensee

          [*] of the Browser Product(s) distributed by or for Licensee

          [*] of the General Product(s), and other non-cited Product(s)
          distributed by or for Licensee

          [*] from the Vector Product(s) [*] thereafter. Licensee shall have the
          right to buyout the royalty obligation for the Vector Products by [*].
          In the event that Licensee proposes to transfer substantially all of
          its rights in the Vector Product line to a third party, Licensee shall
          [*], less any royalties paid by Licensee at the time of such payment
          and such third party shall not be obligated to pay per copy royalties
          to SUN for distribution of the Vector Product(s).

2) Platforms: (check applicable platforms)
          SPARC/Solaris         _________________________
          Win32                 _________________________
          MacOS (68K, PowerPC)  _________________________

Where such versions are not complete as of the Effective Date, the fee covers
the first commercial version shipped by SUN for that platform.

* Confidential treatment requested for redacted portion which has been filed
  separately with the Securities and Exchange Commission.

                                       16
<PAGE>   17

                                   EXHIBIT D

                       CONFIDENTIAL DISCLOSURE AGREEMENT

                                (to be attached)

                                       17
<PAGE>   18
                                   EXHIBIT E

                            DOCUMENT TYPE DEFINITION

In order to ensure interoperability between all Java compliant browsers, SUN
needs to define the exact notation of applets in HTML documents. The format of
the APPLET tag is chosen to be implementation language independent and SGML
compliant. SGML compliance is important if the APPLET tag is to be accepted as
part of the HTML standard in the future.

Example:

     <applet codebase-"http://java.sun.com/people/avh/classes"
              code-"BounceItem.java" width-400 height-300>
     </applet>

The applet tag has the following attributes:

CODEBASE  The base url of the applet. The applet's code is located relative to
          this URL. If this attribute is not specified, it defaults to the
          document's URL.

CODE      The file in which the applet is located. This file is relative to
          base url of the applet, it cannot be absolute.

ALT       Alternate text which can be displayed by text only browsers.

NAME      The symbolic name of the applet. This name can be used by applets in
          the same page to locate each other.

WIDTH     Required attribute which specifies the initial width of the applet in
          pixels.

HEIGHT    Required attribute which specifies the initial height of the applet in
          pixels.

ALIGN     The alignment of the applet, similar to the img tag.

VSPACE    The vertical space around the applet, similar to the img tag.

HSPACE    The horizontal space around the applet, similar to the img tag.

Note that the position of the applet in the page is determined by the width,
height, align, vspace and hspace attributes just like the img tag.

Applets can access the above attributes using the getParameter0 method call
defined in the Applet class. All attribute/parameter names are automatically
folded to lower case. Applets that require parameters in addition to the
predefined ones need to use the param tag. It is unfortunately not legal in SGML
for a tag to have an arbitrary list of attributes. That is why additional applet
parameters explicitly using the PARAM tag have to be named. For example:

     <applet code-"DateItem.class" code-"The Date" width-200 height-40>
     <param name-"speaker" value-"avti">
     <param name-"translator" value-"Dutch Time">
     </applet>

In addition to the ALT tag, Licensee can include additional text and markup
before the applet end tag. Java compliant browsers will ignore this text, but
browsers that do not understand the applet tag will display it instead of the
applet. For example:

     <applet codebase-classes code-ImageLoop.class width-100 height-100>
     <param name-imgs value-"images/duke">

                                       18
<PAGE>   19
If Licensee were using a Java enabled browser, Licensee would see an animation
instead of this static image. <p>
                              <img src="images/duke/T1.gif">
                              </applet>

Below is the formal SGML DTD for the APPLET and PARAM tags.

<!ELEMENT APPLET -- (PARAM*, (%text;)*)>
<!ATTLIST APPLET
     CODEBASE CDATA #IMPLIED        --code base--
     CODE CDATA #REQUIRED           --code file--
     ALT CDATA #IMPLIED             --alternative string--
     NAME CDATA #IMPLIED            --the applet name--
     HEIGHT NUMBER #REQUIRED
     ALIGN (left|right|top|texttop|middle|absmiddle|baseline|bottom|absbottom)
        baseline
     VSPACE NUMBER #IMPLIED
     HSPACE NUMBER #IMPLIED

>

<!ELEMENT PARAM - O EMPTY>
<!ATTLIST PARAM
     NAME NAME #REQUIRED            --The name of the parameter--
     VALUE CDATA #IMPLIED           --The value of the parameter--

>

                                       19

<PAGE>   20

                               TRADEMARK LICENSE

The following terms and conditions governing Java compatibility branding and
trademarks generally ("License") are incorporated by reference into the
Technology License and Distribution Agreement ("TLDA") between SUN and
Licensee, attached hereto. Where this License is more specific than or
inconsistent with the TLDA, the terms of this License shall govern. Otherwise,
the TLDA shall apply. The parties agree that:

1.    DEFINITIONS

      1.1.  "Branded Product" means all online software or tangible copies or
units of any version of Licensee's Products being distributed in association
with any Compatibility Logo.

      1.2.  "Compatibility Logo" means the Java-compatible logo supplied by SUN
to Licensee from time-to-time. The current version of the logo is depicted at
the end of this License.

      1.3.  "Licensee's Products" means only the products described in Exhibit
B of the TLDA.

2.    GRANT OF LICENSE

SUN grants to Licensee a non-exclusive, non-transferable, personal, paid-up,
royalty-free license, within the Territory in Section 3, to use the
Compatibility Logo ("License") as provided herein with respect to each of
Licensee's Products that fully meet the certification requirements of Section
4. Licensee is granted no other right, title, or license to the Compatibility
Logo or any other SUN trademark, and is specifically granted no right or
license to sublicense the Compatibility Logo or any other SUN trademarks. This
License shall apply and pass through to Licensee's distributors who distribute
Licensee's Products as transferred by Licensee (i.e., without any modifications
to the Product, product packaging, documentation or other materials)
("Distributors"). Licensee shall provide notice of this License to and enforce
its terms with Distributors. SUN shall be entitled to enforce the terms of this
License directly against any Distributor in the event Licensee fails to do so.
All subsequent references herein to "Licensee" shall include and apply to
"Distributors".

3.    TERRITORY

Licensee shall not use any Compatibility Logo on or in Licensee's Products
distributed via tangible media (e.g., CD or diskettes) or on any other tangible
materials (e.g., user documentation) in countries other than those listed below
("Territory"), unless SUN expressly agrees in writing beforehand to extend the
Territory (which Sun may refuse to do in its sole discretion). This territorial
restriction shall not apply to on-line distribution of Licensee's Products over
the Internet. Licensee shall pay all costs, including fees for legal services,
registrations, recordals, and foreign language translations associated with any
extension of the Territory requested by Licensee. SUN may eliminate any country
from the Territory if it determines in its sole judgment that use or continued
use of the Compatibility Logo in such country may subject SUN or any third party
to legal liability, or may jeopardize the Compatibility Logo or any SUN
trademark in that or any other country. In such event, Licensee shall promptly
cease all use of the Compatibility Logo in such countries upon written notice
from SUN.

Australia
Austria
Belgium
Benin
Netherlands
Luxembourg
Brazil
Burkino Faso
Cameroon
Canada

                                       21
<PAGE>   21
Central African Republic
Chad
Chile
China (P.R.C.)
Columbia
Congo
Czech Republic
Denmark
Egypt
France
Gabon
Germany
Greece
Guinea
Hong Kong
Hungary
India
Indonesia
Israel
Italy
Ivory Coast
Japan
Mali
Malaysia
Mauritania
Mexico
New Zealand
Niger
Norway
Philippines
Portugal
Russia
Senegal
Singapore
South Korea
Spain
Sweden
Switzerland
Taiwan
Thailand
Togo
Turkey
Ukraine
UAE
U.K.
United States
Venezuela

4.   CERTIFICATION

License applies only to versions of Licensee's Products that have successfully
passed the Java Test Suites made available by SUN to Licensee pursuant to the
TLDA, and which otherwise fully comply with all other compatibility and
certification requirements of the TLDA. Upon thirty (30) days written notice by
SUN no more than two (2) times per calendar year, Licensee shall permit SUN to
inspect and test any Branded Products at a mutually-agreeable location to ensure
that they meet the compatibility requirements of the TLDA. Upon request by SUN,
Licensee shall promptly make any

                                       22

<PAGE>   22
modifications to any version of a Branded Product necessary for it to meet such
compatibility requirements.

5.   LOGO AND TRADEMARK USAGE

Licensee shall use the Compatibility Logo only as specified in any guidelines or
policies made by SUN concerning the appearance, placement or use of the
Compatibility Logo ("Logo Guidelines"). Licensee shall: (i) use only approved
logo artwork provided by Sun, (ii) for tangible media, display the Compatibility
Logo on external product packaging, documentation, and media (disk, CD-ROM,
tape, etc.); (iii) for online versions of Licensee's Product, display the
Compatibility Logo on web pages featuring information about the Product in GIF
images that point to the current Sun Java page (http://java.sun.com) via
hypertext link; (iv) for both tangible-media and online versions, display the
Compatibility Logo on "splashscreens" appearing upon launch of Licensee's
Product, if any, and in general product information screens (e.g., "About",
"Help", "Info"); (v) display the Compatibility Logo on tangible marketing
collateral featuring Licensee's Products, including advertisements and
datasheets; and (vi) not display Compatibility Logo more prominently or larger
than Licensee's company name/logo and product name/logo, wherever displayed.

Licensee shall comply with the current versions of the Sun Trademark & Logo
Policies and the Java/HotJava Trademark Guidelines
[http://java.sun.com/tm_guidelines.html], including but not limited to using the
Java mark as an adjective followed by generic descriptions, marking the Java
mark with a (TM) symbol, and attributing the Java mark as a trademark of Sun
Microsystems, Inc. in a legend on packaging, splashcreens, web page, and other
collateral and materials. Licensee may not include any Sun trademark (e.g., Sun,
Java, HotJava, Solaris, etc.) in Licensee's company, business or subsidiary
names, or in the name of any of Licensee's products, services, technologies, or
web pages. Licensee shall promptly modify any usage and any material that does
not conform to the Logo Guidelines, the Sun Trademark & Logo Policies, or the
Java/HotJava Trademark Guidelines upon notice from Sun specifying the
non-conformance. Licensee shall notify its distributors and customers of any
such non-conformance as to materials or products already distributed, as may be
reasonably requested by Sun.

6.   PROTECTION OF TRADEMARKS AND LOGOS

Sun is the sole owner of the Compatibility Logos (including the marks depicted
therein) and all goodwill associated therewith. Licensee's use of the
Compatibility Logos inures solely to the benefit of Sun. Licensee shall not do
anything that might harm the reputation or goodwill of the Compatibility Logo.
Licensee shall not challenge Sun's rights in or attempt to register the
Compatibility Logo, or any other name or mark owned by Sun or substantially
similar thereto. Licensee shall take no action inconsistent with Sun's rights in
the Compatibility Logo. If at any time Licensee acquires any rights in, or
registrations or applications for, the Compatibility Logo by operation of law or
otherwise, it will immediately upon request by Sun and at no expense to Sun,
assign such rights, registrations, or applications to Sun, along with any and
all associated goodwill. Licensee shall assist Sun to the extent reasonably
necessary to protect and maintain the Compatibility Logo worldwide, including
but not limited to giving prompt notice to Sun of any known or potential
infringement of the Compatibility Logo, and cooperating with Sun in the
preparation and execution of any documents necessary to record this License as
may be required by the laws or rules of any country. Sun may at its option
commence, prosecute or defend any action or claim concerning the Compatibility
Logo in the name.

                                       23

<PAGE>   23

                                AMENDMENT NO. 1
                                     TO THE
                 TECHNOLOGY LICENSE AND DISTRIBUTION AGREEMENT
            BETWEEN SUN MICROSYSTEMS, INC. AND SYMANTEC CORPORATION

     This Amendment Number One (the "Amendment No. 1") to the Technology
License and Distribution Agreement dated December 11, 1995 (the "Agreement") by
and between Sun Microsystems, Inc. and Symantec Corporation ("Licensee"), is
entered into this _____ day of _________, 1999 (the "Effective Date") by and
between the same parties.

                                    RECITALS

WHEREAS Sun and Licensee entered into an Agreement for the purpose of licensing
the Java(TM) Applet Environment and the Java(TM) Compiler; and

WHEREAS Licensee desires to develop and distribute products based upon Sun's
Java(TM) Servlet Development Kit (JSDK), Version 2.0 technology,

NOW THEREFORE, in consideration for the mutual covenants contained herein, the
parties further agree as follows:

1.0  DEFINITIONS

The existing Section 1.13 of the Agreement is deleted and replaced with the
following revised Section 1.13:

     1.13 "Technology" means each specific Java(TM) technology (excluding
Tools) licensed by Sun under the Agreement and described in Exhibit A, in
addition to that technology more fully described in the Exhibit G attached to
this Amendment No. 1.

The following new definitions are added to the Agreement:

     1.17 "Java(TM) Servlet Development Kit, Version 2.0" means version 2.0
only of the Java(TM) Servlet Development Kit (hereafter "JSDK") described in
specifications from Sun, as may be revised by Sun during the Term as described
in Exhibit G.

     1.18 "Java(TM) Test Suites" means the applicable test suites associated
with each Technology, as may be revised by Sun during the Term.

2.0  LICENSE GRANTS

Section 2.0 - LICENSE GRANTS of the Agreement is amended by the addition of the
following subsections:

     2.1e. Sublicensing of JSDK Source Code.

     Licensee may sublicense, solely for the Field(s) of Use identified in
     Exhibit G, and deliver a copy of the Source Code and any Documentation
     bundled with Products for JSDK only (i) to third parties only in
     association with the sublicensing of Licensee Products in source code
     form, and (ii) solely for the purpose of enabling such third party to
     provide support and Bug Fixes for Products. Such arrangements must be
     under a written agreement consistent with the terms contained herein and
     any such third party shall be granted no rights to modify, distribute or
     sublicense the JSDK Source Code. Licensee shall provide Sun notice of any
     such third party licensee.

                                       1

<PAGE>   24
      2.13  Compatibility Requirements.

            (i) Unless otherwise specified in an Exhibit, from time to time
      during the term of the Agreement, Sun will make available to Licensee at
      no cost, Java Test Suites for validating that the portion of Licensee's
      Product which interprets Java bytecodes is compatible with the
      then-current version of the applicable Technology and Standard Extensions.

            (ii) Products must fully comply with the Documentation specified in
      the Exhibit for the corresponding Technology and each release of a Product
      by Licensee must pass the most current applicable Java Test Suite that was
      available from Sun one hundred twenty (120) days before FCS of such
      version of the Product. In the event that Licensee elects to use a version
      of the Technology and/or Standard Extension(s) that is newer than that
      which is required under this Section 2.13, then Licensee agrees to pass
      the Java Test Suite that corresponds to such newer version.

            (iii) If Licensee provides Sun with written notice of the existence
      of a bug in a current Java Test Suite, then Licensee shall be released
      from compatibility with the minimum portion of such Java Test Suite
      necessary to avoid the impact of such bug, until such time as Sun provides
      to Licensee a corrected or new Java Test Suite.

            (iv) Upon request by Sun, Licensee shall promptly make any
      modifications to any Product necessary for it to meet the compatibility
      requirements set out in this Section 2.13.

3.0   MISCELLANEOUS

The existing Section 11.0 of the Agreement is modified to include a revised
Section 11.1 to change the Sun address as follows:

Sun
Sun Microsystems, Inc.
901 San Antonio Road
Palo Alto, California 94303
Attn: V.P. Sales, Software and Technology
cc: General Counsel, Software and Technology

EXHIBITS.

The attached new Exhibit G is added to the Agreement to add the JSDK, version
2.0.

All other terms and conditions of the Agreement remain in full force and effect.

IN WITNESS WHEREOF, the parties have caused this Agreement to be executed by
their duly authorized representatives.

Sun Microsystems, Inc.:                   Licensee:                    APPROVED
                                                                        [INIT]
                                                                      ----------
                                                                      LEGAL DEPT

By: /s/ MALA S. CHANDRA                   By: /s/ [Signature Illegible]
   -----------------------------             ----------------------------------
Name: MALA S. CHANDRA                     Name: [Illegible]
     ---------------------------               --------------------------------
           (Print or Type)                            (Print or Type)

Title: Director, Enterprise Java          Title: Director, Business Development
      --------------------------                -------------------------------
Date: 3/9/99                              Date: March 9, 99
     ---------------------------               --------------------------------

                                       2
<PAGE>   25
                                   EXHIBIT G

              JAVA(TM) SERVLET DEVELOPMENT KIT, VERSION 2.0, JSDK

L DESCRIPTION OF TECHNOLOGY AND DOCUMENTATION:

A. Technology: Java(TM) Servlet Development Kit (JSDK), version 2.0

The Java(TM) Servlet Development Kit (JSDK), version 2.0, can be used to
develop and test server extensions based on the servlet API. Included is a
stand-alone server (called Servletrunner) that can be used to test servlets
before running them in a servlet-enabled web server.

The JSDK serves as the reference Implementation for the Java Servlet API 2.0.
This release will run on top of JDK 1.1.x as well as JDK 1.2

Package javax.servlet (redistributable as source / not modifiable)

      GenericServlet.java
      Servlet.java
      ServletConfig.java
      ServletContext.java
      ServletException.java
      ServletinputStream.java
      ServletOutputStream.java
      ServletRequest.java
      ServletResponse.java
      SingleThreadModel.java
      UnavailableException.java

Package javax.servlet.http (redistributable as source / not modifiable)

      Cookie.java
      HttpServlet.java
      HttpServletRequest.java
      HttpServletResponse.java
      HttpSession.java
      HttpSessionBindingEvent.java
      HttpSessionBindingListener.java
      HttpSessionContext.java
      HttpUtils.java

Package sun.servlet (not redistributable as source / modifiable)

      ServletConnection.java
      ServletLoader.java

                                       3
<PAGE>   26

Package sun.servlet.http (not redistributable as source/modifiable)

     CacheControlHeader.java
     HttpDate.jave
     HttpInputStream.java
     HttpOutputStream.java
     HttpRequest.java
     HttpRequestLine.java
     HttpRequestListener.java
     HttpResponse.java
     HttpServer.java
     HttpServerHandler.java
     HttpServletConfig.java
     HttpSessionImpl.java
     HttpWriter.java
     InvalidRequestException.java
     MessageBytes.java
     MessageString.java
     MimeHeaderField.java
     MimeHeaders.java
     SessionContextImpl.java

Package sun.servlet.util (not redistributable as source/modifiable)

     Ascii.java
     Pool.java
     Queue.java
     QueueEmptyException.java
     QueueFullException.java

Sources are provided for a Unix Shell script and Win32 exe to launch the
servletrunner. These files are modifiable.

B.   Documentation

Source documentation is provided in the form of README.source's in the top
directory. User documentation is provided in the form of a README and a
servlet_tutorial.html file. The README and servlet_tutorial should not be
modified and should be distributed with the final distribution.

II.  FIELD(S) OF USE AND PRODUCT LIST:

Field of Use: For bundling within VisualCafe Enterprise Suite only

Products: VisualCafe Enterprise Suite

                                       4

<PAGE>   27

                               Agreement Amending
                 Technology License and Distribution Agreement
                                    Between
                SUN MICROSYSTEMS, INC. and SYMANTEC CORPORATION

This Agreement ("Agreement") is made and entered into by and between SUN
MICROSYSTEMS, INC. ("Sun") and SYMANTEC CORPORATION ("Symantec") this 9th day of
September, 1999

Symantec and Sun entered into: (i) a Technology License and Distribution
Agreement dated December 11, 1995, as amended (the "TLDA"); and (ii) a letter
agreement dated March 28, 1997 granting Sun the right to distribute Symantec's
Just-in-Time Compiler (the "Letter Agreement"); and

The parties hereto desire to amend the TLDA and the Letter Agreement on the
terms and conditions noted herein.

     NOW, THEREFORE, the parties hereto agree as follows:

     1.   The capitalized terms used and not otherwise defined in this
          Agreement shall have the same meaning as defined in the TLDA.

     2.   The TLDA is hereby amended to provide that Symantec shall have for the
          term of the TLDA, a worldwide, non-exclusive, non-transferable right
          and license with respect to the Java Applet Environment Version 1.2
          and Upgrades thereto (collectively, the "JAE"), to: access, use [*]
          the source code of the Shared Part of the Java Runtime Interpreter,
          while maintaining compatibility as provided in Section 2.4 of the
          TLDA, for the purposes of improving the performance of the JAE (the
          "Improved JAE") and integrating the Improved JAE into Products; (ii)
          distribute Products in binary code form containing the Improved JAE in
          accordance with the terms of Section 2.2 a and b of the TLDA; (iii)
          sublicense the Improved JAE in source code form, in accordance with
          Sections 2.1(b)(iii) and 2.1(d) of the TLDA; and (iv) sublicense the
          Improved JAE in source code form to Sun's other commercial source code
          licensees of the JAE for the sole purpose of integrating the Improved
          JAE into such licensees' products pursuant to the terms of their
          respective commercial JAE source code licenses with Sun.

     3.   The Letter Agreement is amended to clarify that, effective as of
          December 1, 1998, Sun has a perpetual, worldwide, non-exclusive,
          non-transferable right and license, in accordance with Paragraph 4 of
          the Letter Agreement, to: (i) distribute and sublicense Version 3.0
          of Symantec's Just-in-Time Compiler (and any updates thereto; e.g.,
          Versions 3.x.x) in binary form; and (ii) access and modify the source
          code of Version 3.0 of Symantec's Just-in-Time Compiler (and any
          updates thereto).

     4.   Sun acknowledges that: (i) Symantec intends to spinout its Internet
          Tools Group as a separate company (the "Spinout"); and (ii) in
          connection therewith, Symantec desires to transfer to the Spinout all
          of Symantec's rights and obligations under the TLDA, Letter Agreement
          and this Agreement. Sun agrees that if the Spinout is created within
          12 months of the date of this Agreement, Sun shall consent to a one

* Confidential treatment requested for redacted portion which has been filed
  separately with the Securities and Exchange Commission.
<PAGE>   28

          time assignment to and assumption by the Spinout of all rights and
          obligations of Symantec under the TLDA, the Letter Agreement and this
          Agreement, provided that the Spinout will not be directly or
          indirectly owned or controlled by [*], or any entity directly or
          indirectly owned or controlled by any of the forgoing companies, their
          parents, subsidiaries, successors or assigns, at or prior to the time
          of such assignment. The parties acknowledge and agree that Sun's
          consent to the assignment of the TLDA to Spinout shall not affect any
          subsequent assignment of the TLDA. Any such subsequent assignment or
          change of control shall be governed by Section 11.9 of the TLDA. In
          the event of a breach of this covenant, then the TLDA, the Letter
          Agreement and this Agreement, with the exception of Sun's license to
          Version 3.0 of the Just-in-Time Compiler, shall automatically
          terminate. Any fees or royalties owing to Sun at the time of such
          termination shall become immediately due for payment. The parties
          agree that, effective upon any such assignment, the Spinout will be
          bound by and will assume and discharge all obligations of Symantec
          under the TLDA, the Letter Agreement and this Agreement. Sun hereby
          acknowledges and agrees that any transfer of rights in the Vector
          Product(s) to the Spinout shall not be deemed a transfer to a third
          party for purposes of Exhibit C of the TLDA, provided that Spinout
          obtains substantially all of Symantec's rights in the Vector
          Product(s) in connection with such transfer.

     5.   Symantec agrees to provide a written statement indicating Products
          sold, on a quarterly basis, pursuant to Section 4.1 of the TLDA
          whether or not royalties are due. In addition, within 30 days after
          the effective date of this Agreement, Symantec shall deliver to Sun a
          full accounting of all royalties specified in Exhibit C of the TLDA
          previously credited against the [*] royalty buy-out specified therein
          as well as the [*] annual credit against royalties for the Symantec's
          Just-in-time Compiler specified in the Letter Agreement.

     6.   This Agreement may be executed in counterpart originals. Except as
          modified herein, the TDLA and the Letter Agreement remain in full
          force and effect and unmodified.

IN WITNESS WHEREOF, the parties hereto have caused this Agreement to be entered
into as of the date first written above.

SUN MICROSYSTEMS, INC.                     SYMANTEC CORPORATION

By  /s/ [Signature Illegible]              By  /s/ [Signature Illegible]
   ----------------------------------         ----------------------------------

Title Interim VP/GM Java Software          Title VP, Internet Tools
      -------------------------------            -------------------------------

* Confidential treatment requested for redacted portion which has been filed
  separately with the Securities and Exchange Commission.<PAGE>   1

                                                                   EXHIBIT 10.30

                                January 23, 2001

Chief Operating Officer
WellCheck, Inc.
331 Jefferson Street
Oakland, CA 94607

Dear Chief Operating Officer:

        Gary M. Reynolds and Associates, Inc., a Wisconsin corporation ("GMR")
is pleased to confirm the arrangements under which GMR has engaged WellCheck,
Inc. ("Company") to perform certain services in connection with the Pfizer
Screen Test for Health (the "Program"), all as more specifically described
herein. The terms and conditions set forth herein are sometimes hereinafter
referred to collectively as this "Agreement."

        1. Precondition and Obligations. Company shall be obligated to provide
adequate staff to perform the lipid, glucose and blood pressure screenings
("Screenings"), and other services as set forth more fully in the Statement of
Work, attached as Exhibit A. The Company agrees to perform its services for a
minimum of two hundred forty (240) event days and a maximum of two hundred
twenty thousand (220,000) Screenings.

        If the Company is asked to provide other services not specifically
contemplated in the Statement of Work, GMR and the Company shall enter into a
separate agreement covering such additional services to be rendered by the
Company and the fees payable by GMR. Further, GMR agrees to perform the
obligations as set forth in Exhibit B.

        2. Term. The Company's engagement shall commence on the date of this
letter and remain in full force and effect for one (1) year from the date set
forth on the signature page, provided that this engagement may be terminated
pursuant to this Paragraph 2.

           (a) Either party shall have the right to terminate this Agreement in
the event of a default by the other party of a material term or condition, upon
fifteen (15) business days prior written notice to the defaulting party stating
with specificity the alleged default. During said period, the defaulting party
shall have an opportunity to cure any such default or present to the
non-defaulting party an acceptable plan for cure of any default which cannot
reasonably be cured within fifteen (15) day period. Failure to comply with the
plan for cure may result in immediate termination of this Agreement at the
non-defaulting party's discretion.

           (b) GMR may terminate this Agreement without cause upon thirty (30)
days prior written notice to the Company; the Company may terminate this
Agreement without cause upon sixty (60) days prior written notice to GMR.

------------------

Confidential treatment has been requested for portions of this exhibit. The copy
filed herewith omits the information subject to the confidentiality request.
Omissions are designated as [***]. A complete version of this exhibit has been
filed separately with the Securities and Exchange Commission.

<PAGE>   2

           (c) This Agreement may be terminated immediately upon notice to the
other party if GMR or the Company is prohibited by law, regulation or order from
engaging in or utilizing the services or activities described or referred to in
this Agreement.

           (d) This Agreement may be terminated by either party immediately,
upon written notice, if the other party (i) makes a general assignment for the
benefit of creditors, (ii) is adjudicated bankrupt, (iii) files a voluntary
petition for bankruptcy or for reorganization, or effectuated a plan or other
similar arrangement with creditors, or has a petition filed against it for an
adjudication in bankruptcy or reorganization and such petition is not dismissed
within sixty (60) days, or (iv) applies for or permits the appointment of a
receiver or trustee or custodian for any of its property or assets.

           (e) Upon termination by GMR, the Company shall, nevertheless, be
entitled to (i) receive and retain the fees set forth in Paragraph 9 to the
extent such fees are due and payable up to and including the effective date of
termination and (ii) reimbursement for all reasonable expenses paid, incurred or
committed to up to the effective date of termination, provided that such
expenses were approved by GMR in advance and in writing.

        3. Press Release. The Company may issue a press release indicating that
it has entered into a letter agreement with GMR. However, GMR retains the right
to approve the contents of such release prior to publication. The Company
acknowledges that, it may not, without prior permission from Pfizer, Inc., which
approval will not be unreasonably withheld ("Pfizer"), refer to Pfizer or any of
its programs in such press release.

        4. Mutual Warranties. In addition to any other warranties,
representations and covenants in this Agreement, each party expressly warrants
and represents to the other that:

           (a) It is in compliance with, and will continue throughout the term
of this Agreement to comply with, all applicable federal, state and local laws,
rules, regulations, ordinances and orders where failure to do so would have a
material adverse effect on its obligations under this Agreement.

           (b) It is a corporation duly organized, validly existing and in good
standing under the laws of its state of incorporation, and is duly licensed or
qualified to do business as a foreign corporation, and is in good standing in
each jurisdiction wherein the character of the properties owned or leased by it
makes such licensing necessary, in each case where such failure would have a
material adverse effect on its obligations under this Agreement.

           (c) The execution, delivery and performance of the Agreement are not
prohibited by, and do not violate, any provision or result in any material
breach of, (i) its articles of incorporation or bylaws or equivalent
organizational documents or (ii) any contract, indenture, agreement, lease,
permit or license by which it or its properties are bound.

           (d) The Agreement has been duly executed and delivered by it and,
assuming due execution, authorization and delivery of it by the other party,
constitutes the legal, valid and binding obligation, enforceable in accordance
with its terms.

                                      -2-
<PAGE>   3

        5. Company Warranties. The Company further represents and warrants to
GMR that:

           (a) All services rendered in connection with the Program shall be
rendered according to established professional standards in the Company's
industry.

           (b) All services provided by the Company shall be performed according
to specifications, descriptions, or samples provided by the Company.

           (c) As of the date of this Agreement, it has no knowledge of any
pending infringement action against it concerning any intellectual property
which Company will employ in connection with the Screenings.

           (d) In connection with the performance of the Screenings rendered in
connection with the Program, TEAMS (as defined in Exhibit A) will (i) capture
participant test data, (ii) store the data in a database, (iii) provide reports
on test results and (iv) provide summary reports of the tests conducted.

        6. Disclaimer. EXCEPT FOR THE WARRANTIES SET FORTH IN PARAGRAPHS 4 AND
5, NEITHER PARTY MAKES ANY WARRANTIES OR CONDITIONS TO THE OTHER OR ANY OTHER
THIRD PARTY, EXPRESS, STATUTORY, IMPLIED, OR OTHERWISE, AND EACH PARTY
SPECIFICALLY DISCLAIMS THE IMPLIED WARRANTIES AND CONDITIONS OF MERCHANTABILITY,
FITNESS FOR A PARTICULAR PURPOSE AND NON-INFRINGEMENT WITH RESPECT TO ANY
SERVICES OR OBLIGATIONS ASSUMED UNDER THIS AGREEMENT.

        7. Indemnification.

           (a) Each party (an "Indemnifying Party") agrees to indemnify, defend
and hold harmless the other party (an "Indemnified Party"), its directors,
officers and controlling persons from and against any and all losses, claims,
damages, expenses and all other liabilities, including but not limited to, costs
and attorney's fees arising out of or in connection with third party claims
alleging (i) the breach of any representation, warranty, covenant of this
Agreement attributable to any Indemnifying Party or its agents, assigns,
contractors or employees; or (ii) the negligence of any Indemnifying Party or
its agents, assigns, contractors or employees; or (iii) property damage, bodily
injury and death proximately caused by the Indemnifying Party or its agents,
assigns, contractors or employees; provided that the Indemnified Party shall:
(x) promptly notify the Indemnifying Party in writing of the claim; (y) provide
the Indemnifying Party sole control over the defense and/or settlement of such
claim, at the Indemnifying Party's expense and choice of counsel; and (z)
provide full information and reasonable assistance with respect to such claim.
The Indemnified Party may join in defense of the claim with counsel of its
choice at its expense.

           (b) Company agrees to indemnify, defend and hold harmless GMR, its
directors, officers and controlling persons from and against any and all losses,
claims, damages, expenses and all other liabilities, including but not limited
to, costs and attorney's fees arising out of or in connection with third party
claims alleging the infringement by Company of any parent, copyright, trademark
or trade secret right; provided that GMR shall: (x) promptly notify Company in
writing of

                                      -3-
<PAGE>   4

the claim; (y) provide Company sole control over the defense and/or settlement
of such claim, at Company's expense and choice of counsel; and (z) provide full
information and reasonable assistance with respect to such claim. GMR may join
in defense of the claim with counsel of its choice at its expense.

           (c) The Indemnifying Party agrees that, without the prior written
consent of the Indemnified Party, it will not settle, compromise or consent to
entry of any judgment in any pending or threatened claim, action or proceeding
in respect of which indemnification could be sought under this Paragraph
(whether or not one or more parties entitled to seek such indemnification are
actual or potential parties to such claim or proceeding), unless such
settlement, compromise or consent includes an unconditional release of such
other party from and against all liability arising out of such claim, action or
proceeding.

           (d) If multiple claims are asserted in any litigation or other
proceeding, including an arbitration, and indemnification as to at least one of
such claims is permitted under applicable law and provided for under this
Agreement, the parties agree that any judgment or award shall be conclusively
deemed to be based on claims as to which indemnification is permitted and
provided for, except to the extent the judgment or award expressly states that
the judgment or award, or any portion thereof, is based solely on a claim or
claim as to which indemnification is not available.

           (e) The obligations of the parties to this Agreement to indemnify,
defend and hold harmless the other will survive the termination or expiration of
this Agreement for a period of two (2) years from the date of such termination
or expiration.

        8. Limitation of Liability. EXCEPT FOR LIABILITY UNDER PARAGRAPHS 7, IN
NO EVENT SHALL EITHER PARTY HAVE ANY LIABILITY FOR ANY CONSEQUENTIAL, INDIRECT,
INCIDENTAL OR SPECIAL DAMAGES, HOWEVER CAUSED AND ON ANY THEORY OF LIABILITY,
WHETHER FOR BREACH OF CONTRACT, TORT (INCLUDING NEGLIGENCE), OR OTHERWISE,
ARISING OUT OF OR RELATED TO THIS AGREEMENT, EVEN IF THE PARTY HAS BEEN ADVISED
OF THE POSSIBILITY OF SUCH DAMAGES, AND NOTWITHSTANDING THE FAILURE OF ESSENTIAL
PURPOSE OF ANY LIMITED REMEDY STATED HEREIN.

        9. Fees and Expenses to the Company. The fees for Screening services
shall be the greater of: (i) the aggregate Screening fees calculated by
multiplying the number of Screenings actually performed in the month by the fee
for Screening services set out in Exhibit C, Part I: Screening Fees or (ii) the
Monthly Minimum (as described below). The Monthly Minimum shall be the product
of (x) a minimum number of tests (set out in Exhibit C, Part I according to
event size) per event day, (y) the fee for Screening services set out in Exhibit
C, Part I and (z) the actual number of event days. Any other fees for services
described in Exhibit C, Part II: Other fees shall be payable according to the
per service fee quoted in Schedule C, Part II. In addition to the costs
described in Exhibit C, Parts I and II, any other Reimbursable Expenses as set
out in Exhibit C, Part III: Reimbursable Expenses shall be payable to Company
for amounts actually incurred (i.e., without markup). The Screening Fees, the
Other Fees and Reimbursable Expenses are hereinafter collectively referred to as
the "Contract Payables." GMR shall bear the expense of and shall arrange for all
air travel and automobile rentals for Company and its staff.

                                      -4-
<PAGE>   5

           Notwithstanding the above, Company may not invoice for, and GMR is
not responsible for paying, any amount of Contract Payables which, in the
aggregate, exceeds the bottom-line contract estimate found in Exhibit C, unless
any such excess has been approved by GMR in advance and in writing.

           In consideration of the significant costs to Company associated with
the installation and customization of the Services, within ten (10) days of
execution of this Agreement, GMR agrees to pay Company an advance of $500,000
(the "Advance"). Company will first apply the Advance to any fees due Company
for Screenings performed in accordance with this Agreement and Reimbursable
Expenses. Upon exhaustion of the Advance, Company shall invoice GMR for
Screenings and Reimbursable Expenses as set forth below in this Paragraph 9. In
the event of termination other than due to (1) a material breach by GMR pursuant
to Paragraph 2(a) or (2) termination for GMR's convenience pursuant to Paragraph
2(b) for a reason other than GMR's failure to consummate a Project Agreement
with Pfizer, Company shall refund any remaining Advance.

           On or about the first (1st) of each month, Company will submit an
invoice to GMR indicating Screening fees and Reimbursable Expenses incurred
during the prior month. All payments by GMR will be net 30 days. For
non-contested amounts not paid within 40 days of the invoice date, GMR will pay
Company one and one half percent (1.5%) interest per month on the unpaid
balance, or the maximum amount permitted by law, whichever is less, until all
past due amounts are satisfied. GMR shall further be responsible for all costs
incurred by Company in connection with the recovery of any non-contested, past
due fees, including professional fees and legal costs.

        10. Insurance. Each party shall, at its own expense, secure and maintain
commercial general liability insurance in the amount of not less than five
million dollars ($5,000,000) to insure against liability arising from bodily
injury, property damage, personal injury or death; commercial automobile
liability for all owned, non owned and hired automobiles with bodily injury and
property damage limit of not less than two million dollars ($2,000,000) combined
single limit; statutory workers' compensation insurance meeting all state and
local requirements, including coverage for employer's liability with limits of
no less than five hundred thousand dollars ($500,000). The Company agrees to
secure and maintain professional liability insurance in the amount of no less
than five million dollars ($5,000,000) covering the Screenings.

           Evidence of real and personal property insurance, on a replacement
cost basis, must be provided to the other party prior to signing this contract.
All insurance contracts must be with insurers possessing an A.M. Best rating of
not less than A or A-. Each party shall provide the other with certificates of
insurance naming the other as an additional insured, evidencing the existence of
such insurance within ten (10) days after execution of this Agreement.

        11. Confidential Information. During the term of this Agreement both
parties may receive trade secrets from the other, including, but not limited to,
financial information, product plans, business plans, trade secrets, technology
diagrams, designs, drawings, sketches, flow charts, or any other proprietary
information, whether transmitted orally, in writing, or by any other media,
which (i) when marked as "Confidential," if transmitted in writing or (ii) when
transmitted orally,

                                      -5-
<PAGE>   6

and thereafter designated as confidential in a written memorandum, shall be
treated as "Confidential Information" under this Agreement.

           Both parties agree: (i) to use Confidential Information solely in
accordance with the provisions of this Agreement; and (ii) not to disclose, or
permit to be disclosed, either directly or indirectly, Confidential Information
to any third party without the other's prior written consent. Each party shall
safeguard the Confidential Information of the other party using the same
measures it uses to protect its own Confidential Information, but in no event
shall a party use less than reasonable care.

           Neither party to this Agreement bears responsibility for safeguarding
information that is: (w) publicly available, (x) obtained from third parties not
under confidentiality restrictions, (y) independently developed without
reference to Confidential Information, or (z) required to be disclosed by order
of a court or other governmental entity; provided, however, that the receiving
party shall provide notice as soon as reasonably practicable to the disclosing
party and shall provide reasonable assistance to the disclosing party to obtain
a protective order or otherwise prevent public disclosure of such Confidential
Information, and such Confidential Information shall only lose its confidential
protection for purposes of such legal disclosure.

        12. Relationship of Parties. The relationship of the parties established
by this Agreement is that of independent contractors, and nothing contained in
this Agreement should be construed to give either party the power to direct or
control the day-to-day activities of the other, or be construed to give either
party the authority to direct the manner of performance of the other party's
obligations under this Agreement. Neither party, nor its employees or agents
should be considered the employees or agents of the other party. Each party
assumes exclusive liability for all contributions, taxes or payments required to
be made because of its personnel by the federal and state Unemployment
Compensation Acts, Social Security Acts and all amendments thereto, and by all
other current and future acts, state of federal requiring payment by Company on
account of such personnel performing the Screenings under this Agreement. The
parties should not be deemed partners or joint-venturers of each other, and all
financial and other obligations associated with each party's business are the
sole responsibility of that party.

        13. Assignment and Delegation. Neither party may assign its rights or
obligations under this Agreement without the prior written consent of the other
party, which consent shall not be unreasonably withheld; provided, however, that
each party shall have the right to assign this Agreement without the other
party's consent: (i) to a parent corporation or entity; (ii) to any subsidiary
corporation or entity; or (iii) in connection with the sale of all or
substantially all of its assets. Any attempted assignment in violation of this
Paragraph 13 shall be null and void. This Agreement shall inure to the benefit
of and be binding upon any successors and permitted assigns.

        14. Attorney's Fees. If any action at law or in equity is necessary to
enforce the terms of this agreement, the prevailing party shall be entitled to
reasonable attorney's fees, costs and expenses, in addition to any other relief
to which such prevailing party may be entitled.

                                      -6-
<PAGE>   7

        15. Governing Law. This Agreement shall be governed by, construed and
interpreted in accordance with the internal laws of the State of New York
without regard to its choice of law provisions.

        16. Notices. All invoices and any notices which are required or which
may be given under this Agreement shall be deemed given upon the earlier of
receipt or five (5) days after mailing by certified mail, return receipt
requested, or hand delivery by messenger or express service, to the following
addresses, or to such other address as each party may specify to the other in
writing from time to time.

                    If to GMR:

                    Gary M. Reynolds and Associates, Inc.
                    Attention:  Gary M. Reynolds, Chief Executive Officer
                    2725 South Moorland Road
                    New Berlin, WI 53151

                    If to the Company:

                    Chief Operating Officer
                    WellCheck, Inc.
                    331 Jefferson Street
                    Oakland, CA 94607

        17. Counterparts. This Agreement may be executed in counterparts each of
which when so executed and delivered shall be deemed to be an original and all
of which together shall constitute one instrument.

        18. Severability. The unenforceability, invalidity or illegality of any
provision of this Agreement shall not affect or impair the continuing
enforceability or validity of any other part, all of which shall survive and be
valid and enforceable.

        19. Entire Agreement. This Agreement, including all Exhibits attached
hereto, sets forth the final and complete understanding of the parties with
respect to this subject and there are no other representations or warranties
with respect to this Agreement. This Agreement supersedes all prior discussions,
agreements and undertakings relating to the subject matter. It is further agreed
that the respective rights, interests, understandings, agreements and
obligations of the parties may not be amended, modified or supplemented in any
respect except by a subsequent written instrument evidencing the express written
consent of the party to be charged. Any terms inconsistent with or additional to
the terms set forth in this Agreement which may be included in an
acknowledgement, invoice or other document of either party shall not be binding
on the other.

        20. Arbitration. Any dispute or controversy arising out of, relating to
or in connection with this Agreement will be settled by binding arbitration to
be held in New York, New York in accordance with the rules mutually agreed upon
by the parties or, in the absence of such agreement, in accordance with the then
prevailing rules of the American Arbitration Association. All disputes under
$100,000 shall be heard by one arbitrator; and all disputes over such amount
shall be heard by

                                      -7-
<PAGE>   8

a panel of three arbitrators. The award of the arbitrators, which may include
injunctions, will be final, conclusive and binding on the parties; and judgement
may be entered upon it in any court of competent jurisdiction. The parties
hereby consent to personal jurisdiction and to enforcement of such award in any
court of competent subject matter jurisdiction in the State of New York. All
arbitration proceedings pursuant to the terms of this Paragraph 20 shall be
maintained in confidence by all parties. All applicable statutes shall be tolled
while the procedures specified in this Paragraph 20 are pending. The parties
shall take such action, if any, required to effectuate such tolling.

        21. Equitable Relief. Notwithstanding Paragraph 20, the parties may
apply to any court of competent jurisdiction for a temporary restraining order,
preliminary injunction, or other interim or conservatory relief, as necessary,
without breach of this Agreement and without abridgment of the powers of an
arbitrator.

        This Agreement shall not be effective until executed by duly authorized
officers of each party.

        Please indicate your acceptance of these provisions, conditions and
terms by signing and returning to us both copies. We will forward one fully
executed copy to you. We look forward to working with you on this assignment.

                                          Very truly yours,

                                          GARY M. REYNOLDS AND ASSOCIATES, INC.

                                          By: /s/ Gary M. Reynolds
                                              ---------------------------------
                                              Gary M. Reynolds,
                                              Chief Executive Officer

        The foregoing provisions, terms and conditions are hereby agreed to the
23rd day of January 2001.

                                          WellCheck, Inc.
                                          (the "Company")

                                          By: /s/ Warren E. Pinckert II
                                              ---------------------------------
                                              Warren E. Pinckert II, President

                                      -8-
<PAGE>   9

                                    EXHIBIT A

                                STATEMENT OF WORK

        Company Obligations. During the term of this Agreement and subject to
the terms and conditions set forth herein, Company agrees to provide: (i) lipid,
glucose and blood pressure screenings as well as counseling related to those
screenings (the "Screenings"), (ii) hardware installation and customization of
Company's proprietary lipid, glucose and blood pressure testing system ("TEAMS")
on GMR's mobile marketing vehicles known as Lipitor trucks ("Trucks") necessary
to conduct the Screenings (subject to GMR's procurement of Pfizer approval of
TEAMS as set forth in Exhibit B, (iii) maintenance and support of TEAMS
("Maintenance"), and (iv) participant data and reports of the Screening results
(the "Reports"), (collectively, the "Services"). Company will retain the sole
and exclusive right to control or direct the manner or means by which the
Services are performed and may subcontract or assign any or all of its
obligations and rights under this Agreement; provided Company remains
responsible for the performance of all of its obligations hereunder.

        Ownership. Company expressly retains all right, title, and interest in
and to TEAMS (and any customizations thereof), its documentation, manuals and
its Confidential Information and GMR shall have no interests or rights in TEAMS
other than the limited rights granted to GMR under this Agreement. Further, any
installations of hardware pursuant to this Agreement will remain the property of
Company and will not become permanent fixtures of the Trucks. Further, to the
extent that any enhancements, modifications and/or derivative works, or other
materials or deliverables are developed by or on behalf of Company, all such
materials will be owned by Company.

        Notices. GMR shall not remove any Company Trademark, copyright or other
proprietary notices from any part of TEAMS, Company provided hardware, or other
sales and marketing materials, and shall reproduce such notices on any copies,
in whole or in part, of such materials made by GMR in GMR's marketing literature
and documentation.

        Participant Data. GMR and Company owns any participant data collected in
connection with the Screenings including, names, addresses, demographic
information, answers to risk assessment questionnaires, and test results
("Participant Data"). Company shall hold the Participant Data in trust. Each
party agrees to use any such data only in accordance with applicable laws, with
each party's respective privacy policies, and Company may not otherwise make use
of the data except with GMR's permission.

<PAGE>   10

        Billing. GMR will be billed on the basis of the number of people
screened, with the following exceptions:

        -       Any minimums specified in the Agreement
        -       Overtime
        -       Outsourced Licensed Medical Personnel
        -       Travel fees
        -       Equipment
        -       Logistics/Coordination fees
        -       Forms
        -       Shipping Charges

                                      A-2
<PAGE>   11

                                    EXHIBIT B

                                 GMR OBLIGATIONS

        Regulatory Approval. GMR will secure any necessary Pfizer regulatory
committee approval of TEAMS. Company will support this process by providing
information as reasonably requested by GMR. Company's obligation under Exhibit A
to install TEAMS and perform the Services is subject to GMR's procurement of
such approval.

        Storage and Transportation. Company will ship supplies in connection
with the Screenings F.O.B. GMR's warehouse located in New Berlin, WI. Upon
receipt by GMR at its warehouse, risk of loss, but not title, shall pass to GMR.
GMR shall be responsible for complying with all handling, storage and
transportation guidelines provided by or on behalf of Company with such
supplies. Each party, as applicable, shall ensure the supplies are shipped in
appropriate packaging and shall maintain insurance against damage to the
supplies. GMR will, at its expense, store and subsequently deliver such supplies
to the event locations on event days as mutually agreed by the parties. To the
extent that a failure materially impairs Company's ability to perform the
Screenings, Company shall be relieved of all of its obligations under this
Agreement as they pertain to specific event days where Company has requested
certain supplies necessary for the Screenings and GMR was unable to deliver such
supplies.

        GMR will provide carrying boxes, display tables and display casings for
the Company hardware used in connection with the Screenings. GMR will be
responsible for the transportation, set-up and breakdown of event displays. GMR
shall be responsible for, and shall reimburse Company for any expenses
associated with damaged or mishandled supplies.

        Customizations. GMR will be responsible for all changes in wiring,
mounting systems, and storage inside and outside of the Trucks. GMR will provide
two dedicated 30 amp power circuits to support the TEAMS automation system.

        Maintenance. GMR will be solely responsible for the upkeep and
maintenance of all Trucks and shall do so in a prudent and reasonable manner.

<PAGE>   12

                                    EXHIBIT C

                                SERVICE ESTIMATE

<TABLE>
<S>     <C>                                                                                           <C>
I.      SCREENING FEES

-       Lipid Panel and Glucose, BP and Counseling

        -       425 Event days x 200 Screenings @ $[***]                                              $[***] (small event)

        -       125 Event days x 400 Screenings @ $[***]                                              $[***] (medium event)

        -       50 Event days x 600 Screenings @ $[***]                                               $[***] (large event)

        SubTOTAL                                                                                      $[***]

-       Data Capture and Reporting using "TEAMS" System

        -       425 Event days x 200 Screenings @ $[***]                                              $[***]

        -       125 Event days x 400 Screenings @ $[***]                                              $[***]

        -       50 Event days x 600 Screenings @ $[***]                                               $[***]

                SubTOTAL                                                                              $[***]

II.     OTHER FEES

-       Per hour fee over eight hours per work day billed at $[***] per hour per
        staff member, not to exceed a ten-hour day (Estimate - $[***] x 2 hrs x
        8 staff members x 60 event days)                                                              $[***]

-       Per Diem Travel estimates for Company Staff (Invoiced at $[***] per
        Company employee per day with a minimum of 3 travel/event days per
        program.                                                                                      $[***]

-       Logistics/Coordination Fee
        To be invoiced equally over the duration of
        the program (i.e., 16 months at $[***])                                                       $[***]

        -       Review of regulatory issues

        -       Licensure fees

        -       Company staff and logistics coordination

        -       Professional liability

        -       Biohazard waste removal

        -       Policy and procedures compliance
</TABLE>

-----------------

[***] Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

<PAGE>   13

<TABLE>
<S>     <C>                                                                                           <C>
III.    REIMBURSABLE EXPENSES

-       Outsourced Licensed Medical Personnel needed in accordance to meet
        specific state regulatory requirements (Estimate - $[***]/hour x 8 hours
        x 4 staff x 30 event days)                                                                    $[***]

-       Welch-Allyn Wall-mounted Blood Pressure/Pulse Units (16)
        Includes:        Small, adult and large cuffs
                         Back-up manual equipment                                                     $[***]

-       Printing of Consent/Release forms (To be billed at actual incurred cost)                      $[***]

-       Shipping Charges (To be billed at actual incurred cost)                                       $[***]

        (ESTIMATED) TOTALS                                                                            $[***]
</TABLE>

-----------------

[***] Confidential treatment requested pursuant to a request for confidential
treatment filed with the Securities and Exchange Commission. Omitted portions
have been filed separately with the Commission.

                                      C-2

Source: [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}, [{"source": "alea-institute/alea-institute/kl3m-data-edgar-agreements/train-00026-of-00352.parquet"}]]